MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders |
View |
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting |
View |
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees |
View |
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline |
View |
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting |
View |
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees;REJECTS Apollo’s Arguments and Director Slate |
View |
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder |
View |
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan |
View |
MediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd. |
View |
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June |
View |
MediPharm Labs Alerts Shareholders to Alligations Made Against Regan McGee in Multiple Litigation Filings |
View |
MediPharm Labs Raises Concerns About Poorly Qualified Dissident Nominees |
View |
MediPharm Labs Files Proxy Materials, Issues Chair’s Letter to Shareholders |
View |
MediPharm Labs Responds to Dissident Shareholder's Filing |
View |